A CD3/CD28 microbead-based HIV-1 viral outgrowth assay

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Latently infected resting CD4 T cells are a key barrier to HIV-1 eradication.
• Standard viral outgrowth assays (VOA) use phytohaemagglutinin (PHA) or anti-CD3 antibodies to activate T cells.
• Measuring the HIV-1 reservoir is crucial for developing effective eradication strategies.

Discussion:

• This study compared a novel anti-CD3/CD28 microbead-based assay with the traditional PHA/feeder assay for quantifying the HIV-1 reservoir.
• Both assays demonstrated comparable sensitivity in detecting latently infected cells.
• The PHA/feeder assay successfully detected virus in all 10 patients, while the CD3/CD28 assay did not yield virus in two patients.

Key Insights:

• The CD3/CD28 bead-based assay is a simpler, feeder-free alternative to the PHA/feeder assay.
• The novel assay requires less labor and fewer resources.
• Comparable sensitivity suggests the CD3/CD28 assay is a viable option for HIV-1 reservoir quantification.

Outlook:

• Further validation of the CD3/CD28 bead-based assay in diverse patient populations is warranted.
• This simplified assay could accelerate research into HIV-1 eradication strategies.
• Optimization of the CD3/CD28 assay may improve its sensitivity and broaden its applicability.